Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Multiple Myeloma 2 Urinary Bladder Neoplasms 1 Recurrence 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Advanced Cancer 1

Interventions

Gemcitabine 79 Cisplatin 56 pembrolizumab 32 Paclitaxel 28 Carboplatin 24 Docetaxel 19 Radiotherapy 17 Mitomycin 16 Doxorubicin 15 atezolizumab 14 BCG Vaccine 14 Nivolumab 13 Cystectomy 13 Filgrastim 11 vinflunine 10 Methotrexate 10 Vinblastine 9 Fluorouracil 9 5-aminolevulinic acid hexyl ester 9 Sunitinib 7 Early Intervention, Educational 7 durvalumab 6 avelumab 6 Taxes 6 Methods 6 Cystoscopy 6 Albumin-Bound Paclitaxel 6 enfortumab vedotin 5 Trastuzumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urinary Bladder Neoplasms × lirilumab × Clear all

NCT03532451 2024-09-19

PrE0807

PrECOG, LLC.

Phase 1 Completed

43 enrolled 15 charts

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡